Literature DB >> 24579923

A randomised controlled trial of intra-uterine insemination versus in vitro fertilisation in patients with idiopathic or mild male infertility.

Hossam Elzeiny1, Claire Garrett, Manuela Toledo, Kate Stern, John McBain, Hugh William Gordon Baker.   

Abstract

BACKGROUND: The cause of infertility is unexplained or poorly explained in 30-40% of couples undergoing standard investigations, and treatment ranges from expectant management to IUI and IVF. AIMS: The aim of this study was to compare the clinical pregnancy rates and costs of intra-uterine insemination (IUI) and in vitro fertilisation (IVF) in women where the same ovarian stimulation led to the development of two or three mature follicles.
METHODS: A randomised controlled clinical trial compared the efficacy of IUI and IVF in a tertiary fertility centre (ISRCTN28780587). Primary outcome measures were fetal heart positive pregnancy rate and cost per live birth. The selection criteria were age: females 18-42 years and males 18-60 years, infertility for one year or more, no IVF or IUI for 12 months prior to the trial, and no coital, tubal or ovulatory disorders, oligospermia, untreated endometriosis or contraindication for multiple pregnancy. All women (n = 102) had the same dose FSH stimulation protocol. Those who developed two or three preovulatory follicles were randomised 3:1 to IUI (n = 33) or IVF (n = 10). IUI or IVF was performed 36 h after hCG administration with single or double embryo transfer on day two.
RESULTS: Clinical pregnancy rates (40% vs 12%, P = 0.04) and live birth rate (40% vs 6%, P = 0.01) were higher for IVF than IUI. The cost per live birth was AU$8735 for IVF compared with $42,487 for IUI.
CONCLUSIONS: This study provides evidence that IVF is more successful and cost-effective than IUI using the same doses of FSH. Further confirmatory studies are required.
© 2014 The Royal Australian and New Zealand College of Obstetricians and Gynaecologists.

Entities:  

Keywords:  cost-effectiveness; in vitro fertilisation; intra-uterine insemination; mild male factor infertility; poorly explained subfertility

Mesh:

Year:  2014        PMID: 24579923     DOI: 10.1111/ajo.12168

Source DB:  PubMed          Journal:  Aust N Z J Obstet Gynaecol        ISSN: 0004-8666            Impact factor:   2.100


  6 in total

Review 1.  Intrauterine insemination + controlled ovarian hyperstimulation versus in vitro fertilisation in unexplained infertility: a systematic review and meta-analysis.

Authors:  Anupa Nandi; Gangopadhyay Raja; Davinia White; El-Toukhy Tarek
Journal:  Arch Gynecol Obstet       Date:  2021-10-12       Impact factor: 2.344

Review 2.  Evaluation of the Risk of Birth Defects Related to the Use of Assisted Reproductive Technology: An Updated Systematic Review.

Authors:  Dawid Serafin; Beniamin Oskar Grabarek; Dariusz Boroń; Andrzej Madej; Wojciech Cnota; Bartosz Czuba
Journal:  Int J Environ Res Public Health       Date:  2022-04-18       Impact factor: 4.614

Review 3.  In vitro fertilisation for unexplained subfertility.

Authors:  Zabeena Pandian; Ahmed Gibreel; Siladitya Bhattacharya
Journal:  Cochrane Database Syst Rev       Date:  2015-11-19

4.  Interventions for unexplained infertility: a systematic review and network meta-analysis.

Authors:  Rui Wang; Nora A Danhof; Raissa I Tjon-Kon-Fat; Marinus Jc Eijkemans; Patrick Mm Bossuyt; Monique H Mochtar; Fulco van der Veen; Siladitya Bhattacharya; Ben Willem J Mol; Madelon van Wely
Journal:  Cochrane Database Syst Rev       Date:  2019-09-05

5.  The Livebirth Rate Per In Vitro Fertilization Cycle Is Higher Than The Cumulative Live Birth Rates of Intrauterine Insemination for Patients of Poseidon Group 3 With Unexplained Infertility.

Authors:  Yixuan Wu; Haiying Liu; Jianqiao Liu
Journal:  Front Endocrinol (Lausanne)       Date:  2021-12-01       Impact factor: 5.555

Review 6.  Growing body of evidence supports intrauterine insemination as first line treatment and rejects unfounded concerns about its efficacy, risks and cost effectiveness.

Authors:  Gulam Bahadur; Roy Homburg
Journal:  JBRA Assist Reprod       Date:  2019-01-31
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.